"BD secures FDA 510 (k) clearance for EnCor EnCompass system" was originally created and published by Hospital Management, a ...

Infectious endocarditis (IE) represents a severe medical condition marked by infectious inflammation of the heart's inner ...

Discover how AI is revolutionizing veterinary radiology, and learn how algorithms support specialists for faster, more ...

VizMark has received U.S. Food and Drug Administration FDA 510k clearance for VM1, a non-metal visual tumor marker designed to provide artifact-free visibility across all major breast imaging ...

Diagnostics and imaging innovation is advancing rapidly, with new screening technologies expanding what's possible in early cancer detection. Providers need clear guidance on how to incorporate ...

BD (NYSE: BDX) announced today that the FDA granted 510(k) clearance for its EnCore EnCompass breast biopsy and tissue ...

A novel integrated molecular imaging approach enables precise localization and quantification of heart damage, as well as accurate identification of disease subtypes. The dual PET/MR and PET/CMR ...

Growth is fueled by the increasing prevalence of musculoskeletal disorders and a focus on personalized care and minimally ...

The integration of artificial intelligence (AI) with imaging has emerged as a transformative force in the field of oral oncology. Oral cancer remains a ...

The need to improve the detection of breast cancer in women with dense breasts has resulted in the use of additional imaging modalities to supplement screening. Supplemental molecular breast imaging ...